AirXpanders, The Musculoskeletal Transplant Foundation and Acelity welcomed as Gold Sponsors of Plastic Surgery The Meeting
Arlington Heights, IL – The American Society of Plastic Surgeons (ASPS) is pleased to announce support from AirXpanders, the Musculoskeletal Transplant Foundation (MTF) and Acelity for Plastic Surgery The Meeting. These companies' generous Gold Level sponsorship supports the 86th annual scientific conference, Plastic Surgery The Meeting, taking place October 6-10 in Orlando.
Plastic Surgery The Meeting is geared toward plastic surgeons, trainees and other allied health professionals interested in translating the continuing medical education and information they receive to improve patient care and outcomes. Plastic Surgery The Meeting has provided generations of plastic surgeons the aesthetic and reconstructive education they need to grow all aspects of their surgical careers and practices.
"We are excited and grateful for the support of AirXpanders, MTF and Acelity for Plastic Surgery The Meeting," said Debra Johnson, MD, president of the American Society of Plastic Surgeons. "The plastic surgery specialty benefits from the great collaboration with these industry leaders who continuously display a dedication to patient safety and improved patient outcomes. We sincerely appreciate their support of our scientific meeting."
AirXpanders is noted for its innovative medical devices to improve breast reconstruction, and MTF is a non-profit service organization dedicated to providing clinically sound, safe allograft tissue. Acelity is regarded for the development of products and therapies for a wide variety of wounds.
The ASPS Premier Support program provides industry partners with increased visibility and greater recognition for their support at Plastic Surgery The Meeting. Partnering with ASPS provides unprecedented opportunities to communicate and engage with aesthetic and reconstructive plastic surgeons from around the world.
"At Acelity, we are committed to providing clinicians with solutions that advance their practice and benefit patients, and we are proud to support efforts that further shared goals," said Ron Silverman, MD, Senior Vice President and Chief Medical Officer of Acelity. "Surgeons trust our therapies because of our commitment to clinical evidence and our long history of changing the practice of medicine. We are dedicated to leveraging our expertise in the field to bring innovative new therapies to clinicians who are leading the advancements in plastic and reconstructive surgery."
"AirXpanders is dedicated to advancing the field of reconstructive surgery and providing plastic surgeons with cutting-edge technology that will enable them to improve a woman's experience as she undergoes breast reconstruction," said Scott Dodson, President and CEO, AirXpanders. "The interest in AeroForm has been tremendous since we began our U.S. launch earlier this year, and we are proud to support Plastic Surgery The Meeting and look forward to continuing our collaboration with ASPS."
"MTF is a non-profit, service organization and leading provider of biologic solutions for patients and surgeons that save and heal lives," said Tom Shaffer, Executive Vice-President Global Sales & Marketing. "Plastic Surgery The Meeting is a unique opportunity for MTF to increase awareness and showcase our reconstructive and cosmetic offerings such as acellular dermal matrices, cartilage, adipose and amnion to plastic surgeons throughout the world. We are proud of our past 30 years serving the medical community and pleased to once again be partnering with ASPS and PSF in the achievement of our shared commitment to quality patient care, education, research and the advancement of science."
For more information, visit our Plastic Surgery The Meeting website.
Founded in 2005, AirXpanders, Inc. (www.airxpanders.com) designs, manufactures and markets innovative medical devices to improve breast reconstruction. The company's AeroForm Tissue Expander System, is used in patients undergoing two-stage breast reconstruction following mastectomy. Headquartered in Palo Alto, California, AirXpanders' vision is to be the global leader in reconstructive surgery products and to become the standard of care in two-stage breast reconstruction. AirXpanders is a publicly-listed company on the Australian Securities Exchange under the symbol "AXP." AeroForm was granted U.S. FDA de novo marketing authorization in 2016, first CE mark in Europe in 2012 and is currently licensed for sale in Australia. For more information, please visit www.airxpanders.com.
About the Musculoskeletal Transplant Foundation
Musculoskeletal Transplant Foundation (MTF) is a nonprofit organization based in Edison, N.J. It is a national consortium comprised of leading organ procurement organizations, tissue recovery organizations and academic medical institutions. As the nation’s largest tissue bank, MTF saves and heals lives by honoring donated gifts, serving patients and advancing science. Since its inception in 1987, the organization has received tissue from more than 115,000 donors and distributed more than 7.5 million in allografts for transplantation. For more information, visit www.mtf.org.
Acelity L.P. Inc. and its subsidiaries are a global advanced wound care company that leverages the strengths of Kinetic Concepts, Inc. and Systagenix Wound Management, Limited. Available in more than 90 countries, the innovative and complementary ACELITY™ product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs nearly 5,000 people around the world.